From the Literature

 

Published: Nov 2016

Very low rate of patient-related adverse events associated with the use of intraoperative cell salvage.
DeAndrade D, Waters JH, Triulzi DJ, et al.
Transfusion 2016;56:2768-2772.
Pub Med
NATA rating :

 

REVIEW by:
P. Van der Linden

 

NATA REVIEW:
This retrospective review confirms that the use of cell salvage intraoperatively is safe, with a rate of patient-related adverse event varying between 0 and 0.006%. Although this very low incidence of adverse events could certainly be related to the highly regulated environment in which cell salvage was performed, it might have been underestimated due to the passive system used to report adverse events.

- Philippe Van der Linden